Brentuximab vedotin (post-ASCT): Powder for I.V. infusion 50 mg; Adcetris® Page last updated: 3 March 2017 Public Summary Document (PSD) November 2016 PBAC Meeting - (PDF 939KB) Public Summary Document (PSD) November 2016 PBAC Meeting - (Word 129KB)